C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf44 | Chromosome 19 open reading frame 44 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf110 | Chromosome 1 open reading frame 110 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C1orf116 | Chromosome 1 open reading frame 116 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C21orf58 | Chromosome 21 open reading frame 58 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C5AR1 | Complement component 5a receptor 1 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C8orf34 | Chromosome 8 open reading frame 34 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CALB2 | Calbindin 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAPRIN2 | Caprin family member 2 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBX2 | Chromobox homolog 2 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC176 | Coiled-coil domain containing 176 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC181 | Coiled-coil domain containing 181 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC24 | Coiled-coil domain containing 24 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCDC64 | Coiled-coil domain containing 64 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA2 | Cell division cycle associated 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK15 | Cyclin-dependent kinase 15 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | Predicted intracellular proteins
| | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CEMIP | Cell migration inducing protein, hyaluronan binding | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CENPA | Centromere protein A | Predicted intracellular proteins
| | | | | Tissue enhanced |
CENPT | Centromere protein T | Predicted intracellular proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | Predicted intracellular proteins
| | | | | Tissue enhanced |
CEP19 | Centrosomal protein 19kDa | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CEP55 | Centrosomal protein 55kDa | Predicted intracellular proteins
| | | | | Tissue enhanced |
CEP85 | Centrosomal protein 85kDa | Predicted intracellular proteins
| | | | | Tissue enhanced |
CGNL1 | Cingulin-like 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) | Predicted intracellular proteins
| | | | | Tissue enhanced |
CHRNA1 | Cholinergic receptor, nicotinic, alpha 1 (muscle) | Disease related genes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | Predicted intracellular proteins
| | | | | Tissue enhanced |